ProteomEdge

ProteomEdge is a Swedish biotech company specializing in absolute protein quantification for proteomics research.

Reviewed by 7wData
Share Email

On this page

Profile

Provides tools for precise measurement of proteins in biological samples using mass spectrometry.

ProteomEdge is a Swedish biotech company specializing in absolute protein quantification for proteomics research. Founded with a focus on mass spectrometry-based protein analysis, the company has developed proprietary technology to enable high-precision measurements of clinically relevant biomarkers. In February 2026, ProteomEdge secured SEK 8 million in follow-on funding led by Navigare Ventures, building on a SEK 7.8 million round in 2025.

The funding supports commercialization of its qRePS™ technology and expansion of its product portfolio, including the DiscoveryEdge™600 panel for plasma proteomics. The company collaborates with academic institutions like the University of Gothenburg's Proteomics Core Facility to make its technology accessible to researchers. Henrik Everberg joined as CEO in August 2025, signaling a shift toward commercial scaling. ProteomEdge's products target translational applications in precision medicine, with a growing emphasis on multiplexed assays for biomarker discovery.

Track ProteomEdge and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Academic research labs studying proteomics
  • Pharmaceutical companies developing biomarkers
  • Core facilities offering proteomics services
  • Clinical researchers in precision medicine

Publicly disclosed clients

  • University of Gothenburg Proteomics Core Facility

Strengths and what to watch

Strengths

  • Proprietary qRePS™ technology for absolute protein quantification
  • Strategic collaboration with Sweden's national research infrastructure (SciLifeLab)
  • Investor backing from Navigare Ventures, a Wallenberg Investments subsidiary

Watch for

  • Dependence on academic funding cycles for growth
  • Competition from established proteomics vendors like Olink and SomaLogic
  • Leadership transition with new CEO in 2025

Recent moves

Key Information

Founded
2023
Headquarters
Stockholm, Sweden

Frequently Asked Questions

What does ProteomEdge do?

ProteomEdge is a Swedish biotech company specializing in absolute protein quantification for proteomics research. It develops mass spectrometry-based tools to precisely measure proteins in biological samples, focusing on clinically relevant biomarkers. Their proprietary qRePS™ technology enables high-precision measurements for academic and pharmaceutical research.

How does ProteomEdge's qRePS technology work?

ProteomEdge's qRePS™ technology enables absolute protein quantification using mass spectrometry. It provides high-precision measurements of proteins in biological samples, particularly for biomarker discovery. The method is designed for translational research, supporting applications in precision medicine and pharmaceutical development.

What funding has ProteomEdge received?

In February 2026, ProteomEdge secured SEK 8 million in follow-on funding led by Navigare Ventures, building on a SEK 7.8 million round in 2025. The funding supports commercialization of qRePS™ technology and expansion of products like the DiscoveryEdge™600 panel.

Who uses ProteomEdge's technology?

ProteomEdge serves academic research labs, pharmaceutical companies, and core facilities focused on proteomics. Notable clients include the University of Gothenburg's Proteomics Core Facility. Their tools are used for biomarker discovery, precision medicine research, and translational applications in clinical settings.

What is the DiscoveryEdge™600 panel?

The DiscoveryEdge™600 is ProteomEdge's plasma proteomics panel launched in February 2026. It enables multiplexed assays for biomarker discovery, expanding the company's product portfolio. The tool is designed for researchers studying protein signatures in precision medicine applications.

How does ProteomEdge compare to Olink or SomaLogic?

ProteomEdge competes with established vendors like Olink and SomaLogic in proteomics. Its differentiation lies in qRePS™ technology for absolute protein quantification via mass spectrometry. The company focuses on high-precision measurements and academic collaborations, though faces competition in biomarker discovery markets.

Sources

  1. proteomedge.com — Company overview, funding announcements, product launches
  2. news.cision.com — SEK 8 million funding round and DiscoveryEdge™600 launch
  3. www.gu.se — Collaboration with University of Gothenburg Proteomics Core Facility
  4. dk.linkedin.com — Background on team expertise in stem cell research